News & Updates
The latest news and advances from the world's most exciting life science cluster.
A potentially groundbreaking novel coronavirus treatment being explored by Seattle’s Infectious Disease Research Institute has received FDA approval to start human trials. Dr. Corey Casper, the Institute’s
Microsoft and Adaptive Biotechnologies are studying how the human immune system reacts to the coronavirus
Microsoft and Adaptive Biotechnologies are spearheading an effort to understand how the human immune system responds to the coronavirus, and why some people become so